Table of Contents Table of Contents
Previous Page  68 / 490 Next Page
Information
Show Menu
Previous Page 68 / 490 Next Page
Page Background

66

SCIENTIFIC PROGRAMME

| PROGRAMME AND EXHIBITION GUIDE

SATURDAY 30 APRIL 2016

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

10:45 > Fingolimod mitigates radiation-induced cognitive deficits by restoring

dentate gyrus neurogenesis

A. Stessin (USA), M. Banu, V. Blaho, S. Ryu

OC-0044

10:55 > Dual pathway inhibition attenuates radiation-induced pulmonary

inflammation and fibrosis

N.H. Nicolay (Germany), M. Dadrich, R. Lopez Perez, U. Wirkner,

P. Peschke, J. Debus, P.E. Huber

OC-0045

11:05 > Radiation induced carcinogenesis of cells with stem cell potential from

breast and thyroid gland

M. Zwar (Germany), N. Hosper, K. Manda, D. Buttler, U. Giesen, R. Nolte,

R. Coppes, G. Hildebrandt

OC-0046

11:15 > Tumour microenvironment response and bone marrow cell migration

after pulsed radiotherapy

K. Reynders (Belgium), E. Wauters, J. Vansteenkiste, H. Decaluwé,

P. De Leyn, K. Nackaerts, S. Peeters, C. Dooms, W. Janssens, D. Lambrechts,

D. De Ruysscher

OC-0047

11:25 > A three stage genome wide association study reveals susceptibility for

late radiotherapy toxicity at the 2q24 locus

J.L. Kane (USA), S.A. Krueger, A. Hanna, T.R. Raffel, G.D. Wilson,

G.J. Madlambayan, B. Marples

OC-0048

Proffered Papers

CLINICAL 1: BREAST

10:45 - 11:45 | AUDITORIUM

Chair: C. Vidali (Italy)

Chair: S. Rivera (France)

10:45 > Trends in the use of postoperative radiotherapy following mastectomy:

a population-based study

S. Corradini (Germany), J. Engel, C. Belka, M. Niyazi

OC-0049

10:55 > Variations in use of hypofractionation for early, node-negative breast

cancer in NSW 2007-2012

G. Delaney (Australia), S. Gandhidasan, F. Terlich, D. Baker, R. Walton,

D. Currow

OC-0050

11:05 > Variability in lymph node delineation for breast cancer radiotherapy:

an AIRO multicenter study

D. Ciardo (Italy), R. Ricotti, B.A. Jereczek-Fossa, A.I.R.O. Breast Cancer

Working Group

OC-0051